galileo life sciences

Managing Partner, Galileo life sciences

Charles-André Brouwers

Charles-André has thirty-year years of experience consulting to the biopharma and medical device industries. He worked closely with the CEOs, Senior Executives, and Boards of many Pharmaceutical and Medtech companies. Previous to founding Galileo Life Sciences, he was Senior Partner and Managing Director at the Boston Consulting Group and before Head of the Life Sciences Group of Capgemini.

Charles-André is a registered representative affiliated with Galileo Global Securities, LLC is a broker-dealer registered with the SEC, a member of the Financial Industry Regulatory Authority (FINRA)

Founding Advisor, Galileo Life Sciences

Paul Sekhri

Paul has decades of experience leading life sciences companies as CEO, Chairman and board member CEO including at vTv Therapeutics, eGenesis, Lycera, Cerimon and ARIAD Pharmaceuticals. He was Chief Strategy Officer at Teva pharmaceutical and Senior Vice President business development and global head, early commercial development at Novartis. Paul is a founding member of Galileo Life Sciences.

Founding Advisor, Galileo Life Sciences

Mark Kessel

Mark has long career in biotech investment. He is known as a pioneer of structured financing. He was a founder and CEO of private equity firm Symphony Capital and a Managing Partner of Shearman & Sterling. Mark is a founding member of Galileo Life Sciences.

Senior Advisor

Carolyn Pratt

Carolyn brings decades of experience in biopharmaceutical development and commercialization. She was a member of Genetic Institute, a biotech pioneer now part of Pfizer. She held senior roles at Johnson & Johnson and RRD international, a drug development company. Prior to her biotech career, Carolyn was an equity analyst at Montgomery Securities and Needham.

Senior Advisor

Evonne Sepsis

Evonne Sepsis has spent over twenty years in healthcare investment banking. Ms. Sepsis founded ESC Advisors, a division of KEMA Partners LLC, a life sciences advisory firm focused on private placements and M&A. KEMA Partners is a FINRA/SIPC member and SEC Registered broker-dealer. Prior to founding ESC Advisors, Ms. Sepsis was head of healthcare investment banking at Susquehanna Financial Group and was a Managing Director at C.E. Unterberg, Towbin. Ms. Sepsis started her investment banking career at Salomon Brothers and before business school, she worked at APM, a healthcare consulting firm.

Executive Advisor

Carlo de Notaristefani

Carlo is an international biopharmaceutical operations senior executive with broad technical, operational, and P&L experience. He has deep expertise in designing, operating, and optimizing complex supply chains. He currently serves on the board of several pharma and CMO companies and advises companies and investors.

In 2020, Carlo joined Operation Warp Speed/Federal Covid Response as the lead advisor for Manufacturing and Supply Chain. His previous roles include Executive VP of Operations at Teva Pharmaceuticals Inc. and President Technical Operations and Global Support Functions for Bristol Myers Squibb.

Chief of Staff

Corinne Bichon

Corinne oversees all office services and human resources activities. She is also the primary point of contact for internal and external stakeholders